A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells

Publisher： Karger

E-ISSN： 1421-9662|137|4|214-219

ISSN： 0001-5792

Source： Acta Haematologica, Vol.137, Iss.4, 2017-05, pp. : 214-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Results of an Autologous Noncryopreserved, Unmanipulated Peripheral Blood Hematopoietic Stem Cell Transplant Program: A Single-Institution, 10-Year Experience

By  

Acta Haematologica, Vol. 110, Iss. 4, 2003-12 ,pp. : 179-183

Karger

Access to resources Recommend Favorite

FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 282-288

Karger

Access to resources Recommend Favorite

Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 81-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple poromas following combination chemotherapy and autologous peripheral blood stem cell transplantation

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 4, 2015-04 ,pp. : 430-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early viral complications following CD34‐selected autologous peripheral blood stem cell transplantation for non‐Hodgkin's lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 348-350

John Wiley & Sons Inc

Access to resources Recommend Favorite